This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
medical: Archive
Buy, Hold, or Fade the Recent Rally in UnitedHealth Group (UNH) Stock?
by Shaun Pruitt
UnitedHealth Group (UNH) stock is still down 40% YTD but has surged more than +20% this month following reports that Warren Buffett, and other billionaire hedge fund managers have taken a stake in the company.
UNHPositive Net Change GSPositive Net Change OXYNegative Net Change BRK.BPositive Net Change IHFPositive Net Change
earnings investing medical
Do Options Traders Know Something About JYNT Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to The Joint Corp. stock based on the movements in the options market lately
JYNTNegative Net Change
medical
NeurAxis Stock Down Following Q2 Earnings Despite Revenue Growth
by Zacks Equity Research
NRXS reports strong second-quarter 2025 revenue growth and lower losses, but gross margin compression remains a key concern.
NRXSPositive Net Change
earnings medical medical-devices
Are Options Traders Betting on a Big Move in Avadel Pharmaceuticals Stock?
by Nandini Tamret
Investors need to pay close attention to Avadel Pharmaceuticals stock based on the movements in the options market lately.
AVDLNegative Net Change
medical
Dow Jones ETF (DIA) Hits New 52-Week High
by Sweta Killa
DIA hits a 52-week high, fueled by Dow's record and a surge in UnitedHealth after Berkshire's major stake disclosure.
UNHPositive Net Change DIANegative Net Change
etfs medical
Insights Into 13F Filings: ETFs to Invest in Like Billionaires
by Sweta Killa
Hedge funds invest in Microsoft, UnitedHealth and homebuilders. ETFs like MAGS, IHF and XHB let you invest like billionaires.
XLVNegative Net Change VHTNegative Net Change XHBNegative Net Change ITBNegative Net Change IHFPositive Net Change MAGSNegative Net Change FNGSNegative Net Change UNHGPositive Net Change
etfs home-builder medical tech-stocks
GILD Stock Up 7% Post Q2 Earnings: Should You Buy Now or Wait?
by Zacks Equity Research
Gilead's Q2 earnings beat and raised 2025 outlook lift shares 7.3%, fueled by HIV gains, Trodelvy strength, and new PrEP launch Yeztugo.
GSKNegative Net Change MRKPositive Net Change GILDNegative Net Change
biotechnology biotechs medical pharmaceuticals
Buffett's Shot in the Arm Sends UnitedHealth Soaring Against the Odds
by Kaibalya Pravo Dey
Buffett's $1.57B bet on UNH sparks a 12% surge, lifting peers despite sector headwinds and recent struggles at the insurer.
UNHPositive Net Change BRK.BPositive Net Change CNCPositive Net Change ELVNegative Net Change
insurance medical
Company News for Aug 18, 2025
by Zacks Equity Research
Companies in The News Are: AMAT, UNH, BRK.A, WFC, LLY
WFCPositive Net Change UNHPositive Net Change LLYNegative Net Change BRK.APositive Net Change AMATPositive Net Change
finance medical semiconductor
Abbott Gains in Nutrition With Adult Segment Leading Growth
by Sridatri Sarkar
ABT Nutrition unit posts steady gains as adult-focused brands like Ensure and Glucerna drive global demand and market share growth.
ABTNegative Net Change NSRGYNegative Net Change DANOYNegative Net Change
medical
QUBT Q2 Earnings Match Estimates, Revenues Miss, Stock Down
by Zacks Equity Research
Quantum Computing posts a wider loss, and revenues lag estimates. However, milestones in quantum tech, NASA contract and index inclusion mark growth steps.
ACLSPositive Net Change LDOSPositive Net Change ANETPositive Net Change QUBTPositive Net Change
earnings medical medical-devices
Volatile Markets? Keep An Eye On These 5 Broker-Friendly Stocks
by Maharathi Basu
Amid market volatility, broker-backed stocks like AXL, BKD, ADNT, ABG and AN stand out for their growth potential and earnings strength.
ANPositive Net Change AXLNegative Net Change BKDPositive Net Change ABGNegative Net Change ADNTNegative Net Change
auto-tires-trucks medical retail
New Strong Sell Stocks for August 15th
by Zacks Equity Research
IMTX, ERJ and BFIN have been added to the Zacks Rank #5 (Strong Sell) List on August 15, 2025.
ERJPositive Net Change BFINPositive Net Change IMTXNegative Net Change
finance medical
Humana, DrFirst Ties Up to Boost Statin Use in High-Risk Patients
by Zacks Equity Research
HUM partners with DrFirst to increase statin use in high-risk patients with diabetes and cardiovascular disease, aiming to close care gaps.
UNHPositive Net Change HUMPositive Net Change MOHPositive Net Change CNCPositive Net Change
medical
Top Research Reports for Lowe's, Bristol-Myers & Marvell Technology
by Mark Vickery
Lowe's leans on Pro-focused strategy and AI-powered retail tools, Bristol-Myers banks on new drug launches to offset legacy declines, and Marvell rides AI-driven data center growth despite consumer softness.
BMYNegative Net Change EIXPositive Net Change LOWNegative Net Change THCNegative Net Change MRVLPositive Net Change GPNNegative Net Change KEQUPositive Net Change
computers medical retail semiconductor
Zacks Industry Outlook Highlights Envista, BioLife Solutions, InfuSystems and MariMed
by Zacks Equity Research
Despite industry headwinds, Envista, BioLife Solutions, InfuSystems and MariMed are leveraging innovation and strategy for growth.
BLFSPositive Net Change INFUNegative Net Change NVSTPositive Net Change MRMDPositive Net Change
medical
Nyxoah Secures FDA Clearance for Genio System to Treat Sleep Apnea
by Zacks Equity Research
NYXH wins FDA approval for its leadless, battery-free Genio sleep apnea therapy, backed by strong trial results.
RMDPositive Net Change LIVNNegative Net Change INSPPositive Net Change NYXHPositive Net Change
medical medical-devices
Cardinal Health to Acquire Solaris Health for Urology Expansion
by Zacks Equity Research
CAH is set to buy Solaris Health for $2.4B, boosting urology presence with 750+ providers and expanding Specialty Alliance reach.
UNHPositive Net Change DVANegative Net Change CAHPositive Net Change MCKNegative Net Change
medical medical-devices
Can Eylea HD and Dupixent Profits Revive Regeneron Stock?
by Zacks Equity Research
REGN banks on Dupixent and Eylea HD gains to offset Eylea's decline while oncology wins strengthen its diversified pipeline.
REGNNegative Net Change SNYPositive Net Change RHHBYPositive Net Change BAYRYPositive Net Change
biotechnology biotechs medical pharmaceuticals
Trinity Biotech's Redesigned CGM Sensor Favored by New Clinical Data
by Zacks Equity Research
TRIB's needle-free CGM+ sensor shows accurate 15-day results with no calibration, slashing costs and boosting access.
ABTNegative Net Change MDTNegative Net Change DXCMNegative Net Change TRIBNegative Net Change
medical medical-devices
Best Momentum Stock to Buy for August 15th
by Zacks Equity Research
ECG, NVT and HROW made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on August 15, 2025.
NVTPositive Net Change HROWNegative Net Change ECGPositive Net Change
computers finance medical
Veru Announces Novel Modified-Release Oral Formulation for Enobosarm
by Zacks Equity Research
VERU unveils a novel modified-release oral enobosarm to enhance fat loss while preserving lean mass in chronic weight loss management.
REGNNegative Net Change LLYNegative Net Change VERUNegative Net Change SRRKPositive Net Change
medical medical-devices
TMO Receives FDA Approval for Oncomine Dx Target Test
by Zacks Equity Research
Thermo Fisher secures FDA approval for its Oncomine Dx Target Test to identify NSCLC patients eligible for HERNEXEOS treatment.
TMONegative Net Change ILMNPositive Net Change EXASNegative Net Change GHPositive Net Change
medical
Will New CEO's Leadership Propel Novo Nordisk's Next Growth Wave?
by Ahan Chakraborty
Maziar Mike Doustdar takes office as NVO's new CEO, bringing a proven global growth record to tackle rising obesity market competition.
NVOPositive Net Change LLYNegative Net Change VKTXPositive Net Change
biotechnology biotechs medical pharmaceuticals
New Strong Buy Stocks for August 15th
by Zacks Equity Research
TEN, ECO, MOS, GEHC and SBFG have been added to the Zacks Rank #1 (Strong Buy) List on August 15, 2025.
TENPositive Net Change MOSNegative Net Change ECOPositive Net Change SBFGNegative Net Change GEHCNegative Net Change
agriculture finance medical transportation